Celularity Inc stock is traded at $0.751, with a volume of 66,111. It is up +5.63% in the last 24 hours and down -51.86% over the past month. Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune disorders. The company operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. It generates the majority of its revenue from the Degenerative Disease segment.
Previous Close:
$0.711
Open:
$0.7163
24h Volume:
66,111
Relative Volume:
0.45
Market Cap:
$24.37M
Revenue:
$26.55M
Net Income/Loss:
-$91.72M
P/E Ratio:
-
EPS:
-$3.58
Net Cash Flow:
-$13.25M
1W Performance:
-7.15%
1M Performance:
-51.86%
6M Performance:
-2.47%
1Y Performance:
-56.34%
1-Day Range:
$0.701$0.775
1-Week Range:
$0.701$0.7999
52-Week Range:
$0.5601$2.55
Celularity Inc Stock (CELU) Company Profile
Name
Celularity IncSector
HealthcareIndustry
BiotechnologyPhone
(908) 768-2170Address
170 PARK AVE, FLORHAM PARK, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS